Central Venous Pressure and Clinical Outcomes During Left-Sided Mechanical Support for Acute Myocardial Infarction and Cardiogenic Shock
Evan H Whitehead, Katherine L Thayer, Daniel Burkhoff, Nir Uriel, E Magnus Ohman, William O'Neill, Navin K Kapur, Evan H Whitehead, Katherine L Thayer, Daniel Burkhoff, Nir Uriel, E Magnus Ohman, William O'Neill, Navin K Kapur
Abstract
Background: Right ventricular failure (RVF) is associated with increased mortality among patients receiving left ventricular mechanical circulatory support (LV-MCS) for cardiogenic shock and requires prompt recognition and management. Increased central venous pressure (CVP) is an indicator of potential RVF. Objectives: We studied whether elevated CVP during LV-MCS for acute myocardial infarction complicated by cardiogenic shock is associated with higher mortality. Methods: Between January 2014 and June 2019, we analyzed hemodynamic parameters during Impella LV-MCS from 28 centers in the United States participating in the global, prospective catheter-based ventricular assist device (cVAD) study. A total of 132 patients with a documented CVP measurement while on Impella left-sided support for cardiogenic shock were identified. Results: CVP was significantly higher among patients who died in the hospital (14.0 vs. 11.7 mmHg, p = 0.014), and a CVP >12 identified patients at significantly higher risk for in-hospital mortality (65 vs. 45%, p = 0.02). CVP remained significantly associated with in-hospital mortality even after adjustment in a multivariable model (adjusted OR 1.10 [95% CI 1.02-1.19] per 1 mmHg increase). LV-MCS suction events were non-significantly more frequent among patients with high vs. low CVP (62.11 vs. 7.14 events, p = 0.067). Conclusion: CVP is a single, readily accessible hemodynamic parameter which predicts a higher rate of short-term mortality and may identify subclinical RVF in patients receiving LV-MCS for cardiogenic shock.
Keywords: Impella RP; cardiogenic shock; central venous pressure; mechanical circulatory support; right heart failure.
Copyright © 2020 Whitehead, Thayer, Burkhoff, Uriel, Ohman, O'Neill and Kapur.
Figures
References
- Konstam MA, Kiernan MS, Bernstein D, Bozkurt B, Jacob M, Kapur NK, et al. . Evaluation and management of right-sided heart failure: a scientific statement from the American Heart Association. Circulation. (2018) 137:e578–22. 10.1161/CIR.0000000000000560
- Bellavia D, Iacovoni A, Scardulla C, Moja L, Pilato M, Kushwaha SS, et al. . Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta-analysis of observational studies. Eur J Heart Fail. (2017). 19:926–46. 10.1002/ejhf.733
- Anderson MB, Goldstein J, Milano C, Morris LD, Kormos RL, Bhama J, et al. . Benefits of a novel percutaneous ventricular assist device for right heart failure: the prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant. (2015) 34:1549–60. 10.1016/j.healun.2015.08.018
- Kapur NK, Esposito ML, Bader Y, Morine KJ, Kiernan MS, Pham DT, et al. . Mechanical circulatory support devices for acute right ventricular failure. Circulation. (2017) 136:314–26. 10.1161/CIRCULATIONAHA.116.025290
- Vetrovec GW, Anderson M, Schreiber T, Popma J, Lombardi W, Maini B, et al. . The cVAD registry for percutaneous temporary hemodynamic support: a prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure. Am Heart J. (2018) 199:115–21. 10.1016/j.ahj.2017.09.007
- O'Neill WW, Grines C, Schreiber T, Moses J, Maini B, Dixon SR, et al. . Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device. Am Heart J. (2018) 202:33–8. 10.1016/j.ahj.2018.03.024
- Basir MB, Schreiber T, Dixon S, Alaswad K, Patel K, Almany S, et al. . Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: the Detroit cardiogenic shock initiative. Catheter Cardiovasc Interv. (2018) 91:454–61. 10.1002/ccd.27427
Source: PubMed